Clinical Trials Browser

Interventional × Neoadjuvant Therapy × Other hematologic neoplasm × Clear all

NCT02326584 2018-05-09

A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute